Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (431-440 of 451) with videos related to

Pageof 46
Sort By:
Journal of Hepatology|October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationAdriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Gastroenterology|December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis BJang-June Park, David K Wong, Abdus S Wahed, et al.
The Lancet. Respiratory Medicine|October 14, 2019
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trialMarcelo Cypel, Jordan J Feld, Marcos Galasso, et al.
The Lancet. Gastroenterology & Hepatology|January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialJason Grebely, Olav Dalgard, Brian Conway, et al.
The American Journal of Gastroenterology|January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 8, 2024
Correction to: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis BHannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Journal of Hepatology|January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
The Lancet. Gastroenterology & Hepatology|January 17, 2019
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology CommissionGraham S Cooke, Isabelle Andrieux-Meyer, Tanya L Applegate, et al.
Pageof 46

Showing results (431-440 of 451) with videos related to

Sort By:
Pageof 46
Journal of Hepatology|October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationAdriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.
Gastroenterology|December 20, 2015
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis BJang-June Park, David K Wong, Abdus S Wahed, et al.
The Lancet. Respiratory Medicine|October 14, 2019
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trialMarcelo Cypel, Jordan J Feld, Marcos Galasso, et al.
The Lancet. Gastroenterology & Hepatology|January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialJason Grebely, Olav Dalgard, Brian Conway, et al.
The American Journal of Gastroenterology|January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 8, 2024
Correction to: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis BHannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Journal of Hepatology|January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
The Lancet. Gastroenterology & Hepatology|January 17, 2019
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology CommissionGraham S Cooke, Isabelle Andrieux-Meyer, Tanya L Applegate, et al.
Pageof 46